Paper · 28314735
Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.
Adams LA and 3 others. Gut, 2017. Cited by 899 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Papers, record 28314735. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28314735
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cardiovascular Diseases | Major topic |
| Colorectal Neoplasms | Major topic |
| Diabetes Mellitus, Type 2 | Major topic |
| Non-alcoholic Fatty Liver Disease | Major topic |
| Osteoporosis | Major topic |
| Renal Insufficiency, Chronic | Major topic |
| Adipokines | |
| Animals | |
| Cytokines | |
| Diet | |
| Gastrointestinal Microbiome | |
| Humans | |
| Incidence | |
| Nutritional Status | |
| Prevalence | |
| Risk Factors |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT06739486 | Efficacy of Sodium Glucose Cotransporter 2 Inhibitors on Non-Alcoholic Fatty Liver Disease | Results |
Source ClinicalTrials.gov
Comments and corrections4
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 28,601,844 | The role of hepatokines in NAFLD-related extrahepatic diseases: culprit or accomplice? | https://conductscience.org/library/papers/28601844 | PubMed |
| Comment in | 29,744,346 | Beyond the liver in patients with non-alcoholic fatty liver disease (NAFLD)-cause for concern? | https://conductscience.org/library/papers/29744346 | PubMed |
| Comment in | 29,744,347 | Non-alcoholic fatty liver disease: beyond the liver is an emerging multifaceted systemic disease. | https://conductscience.org/library/papers/29744347 | PubMed |
| Comment in | 30,498,715 | Non-alcoholic fatty liver disease: a pandemic disease with multisystem burden. | https://conductscience.org/library/papers/30498715 | PubMed |
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by574
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 899 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,943,326 | The MASLD-Heart Axis: Biological Mechanisms, Cardiac Remodeling, and Clinical Implications. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42943326 | PubMed |
| 42,928,099 | Estimated glucose disposal rate stratifies mortality risk, especially in younger adults with cardiovascular-liver-metabolic overlap. | BMC Gastroenterol | 2026 | https://conductscience.org/library/papers/42928099 | PubMed |
| 42,903,976 | Crucial functions of gut microbiota on gut-liver repair. | Hlife | 2025 | https://conductscience.org/library/papers/42903976 | PubMed |
| 42,876,771 | Associations of metabolic dysfunction-associated steatotic liver disease and significant fibrosis phenotypes with glomerular hyperfiltration defined by indexed eGFR. | Front Nutr | 2026 | https://conductscience.org/library/papers/42876771 | PubMed |
| 42,872,281 | Cardiometabolic comorbidity and health outcomes of persons with metabolic dysfunction-associated steatotic liver disease (MASLD) in Ontario, Canada. | Can Liver J | 2026 | https://conductscience.org/library/papers/42872281 | PubMed |
| 42,859,223 | Metabolic dysfunction-associated steatotic liver disease is associated with higher bone mineral density: results from NHANES. | Osteoporos Int | 2026 | https://conductscience.org/library/papers/42859223 | PubMed |
| 42,780,391 | Liver fat fraction negatively correlates with lumbar BMD in normal body mass index postmenopausal women: mediated by bone marrow fat. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42780391 | PubMed |
| 42,718,937 | Association between glycerol triglyceride glucose-related index and cardiovascular disease in individuals with metabolic dysfunction-associated steatotic liver disease: NHANES 1999-2023. | Ther Adv Endocrinol Metab | 2026 | https://conductscience.org/library/papers/42718937 | PubMed |
| 42,712,586 | The association between metabolic dysfunction-associated fatty liver disease and left ventricular mass index in patients with schizophrenia with long-term hospitalization. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42712586 | PubMed |
| 42,621,560 | Benefit of Psyllium with Weight Loss Diet in Preventing Liver Dysfunction in Overweight or Obese Adults with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). | Int J Prev Med | 2026 | https://conductscience.org/library/papers/42621560 | PubMed |
1 to 10 of 574
See all 574 cited byGenes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| PNPLA3 | 80,339 | PubTator's text mining | https://conductscience.org/library/genes/80339 | NCBI Gene |
| TM6SF2 | 53,345 | PubTator's text mining | https://conductscience.org/library/genes/53345 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28314735
GET https://conductscience.org/api/papers/v1/28314735/cited_by?page=2